Bajaj Finserv Healthcare Fund holds 36 instruments (95.56% equity), led by Divi's Laboratories Limited (9.75%), Sun Pharmaceutical Industries Limited (8.96%) and Piramal Pharma Limited (6.36%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Bajaj Finserv Healthcare Fund, managed by Bajaj Finserv Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 36 instruments with an equity allocation of 95.56%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Bajaj Finserv Healthcare Fund's top 10 holdings account for 59.23% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 89.35% of net assets, spread across 5 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 2 positions, with Laurus Labs Limited seeing the largest move (+1.55pp to 3.91%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Laurus Labs Limited | 2.36% → 3.91% | ▲ +1.55 |
| Sun Pharmaceutical Industries Limited | 8.21% → 8.96% | ▲ +0.75 |
| Emcure Pharmaceuticals Limited | 3.84% → 4.03% | ▲ +0.19 |
| Jubilant Pharmova Limited | 0.76% → 0.89% | ▲ +0.13 |
| Stock | Weight | Change |
|---|---|---|
| Divi's Laboratories Limited | 10.55% → 9.75% | ▼ -0.8 |
| Rubicon Research Limited | 6.81% → 6.08% | ▼ -0.73 |
| Apollo Hospitals Enterprise Limited | 6% → 5.51% | ▼ -0.49 |
| Fortis Healthcare Limited | 2.69% → 2.28% | ▼ -0.41 |
| Piramal Pharma Limited | 6.72% → 6.36% | ▼ -0.36 |
| Max Healthcare Institute Limited | 3.35% → 2.99% | ▼ -0.36 |
| Neuland Laboratories Limited | 4.11% → 3.82% | ▼ -0.29 |
| Torrent Pharmaceuticals Limited | 5.03% → 4.78% | ▼ -0.25 |
| GlaxoSmithKline Pharmaceuticals Limited | 1.79% → 1.63% | ▼ -0.16 |
| Aurobindo Pharma Limited | 6.18% → 6.03% | ▼ -0.15 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Bajaj Finserv Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.